Neuromelanin-sensitive MRI as a biomarker for individualized deep brain stimulation in Parkinson's disease: Associations between substantia nigra imaging and therapeutic outcomes

Key Points

• Successful neuromelanin-sensitive MRI predicts therapeutic outcomes in deep brain stimulation.
• Key evidence shows that improvements in motor function and reduced symptoms correlate significantly with imaging results.
• Observational analysis assessed 50 patients, revealing strong associations between substantia nigra imaging and functional outcomes.
• Findings highlight the potential for tailoring deep brain stimulation based on individual neuromelanin biomarkers.